A task authorized by the Council of Scientific and Industrial Research (CSIR) to create human monoclonal antibodies as treatment for COVID-19 diseases will be driven by Bharat Biotech. Reporting this on Friday, the Hyderabad-based immunization maker said however endeavors were in progress for advancement of medications and antibodies for controlling the pandemic, they were moderate…